BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26852106)

  • 21. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEUS in hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in 320 patients - early or late washout matters: a subanalysis of the DEGUM multicenter trial.
    Wildner D; Bernatik T; Greis C; Seitz K; Neurath MF; Strobel D
    Ultraschall Med; 2015 Apr; 36(2):132-9. PubMed ID: 25812115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience.
    Sahani DV; Holalkere NS; Mueller PR; Zhu AX
    Radiology; 2007 Jun; 243(3):736-43. PubMed ID: 17517931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma.
    Iwazawa J; Ohue S; Hashimoto N; Muramoto O; Mitani T
    Eur J Radiol; 2012 Dec; 81(12):3985-92. PubMed ID: 22959287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
    Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
    J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: correlation with microvessel morphology.
    Xiao JD; Zhu WH; Shen SR
    Hepatobiliary Pancreat Dis Int; 2010 Dec; 9(6):605-10. PubMed ID: 21134829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
    Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
    Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extra-hepatic feeding arteries of hepatocellular carcinoma: An investigation based on intra-arterial CT aortography images using an angio-MDCT system.
    Takada K; Ito T; Kumada T; Toyoda H; Tada T; Sone Y; Endo T; Tanaka K; Kitagawa H; Ichikawa K
    Eur J Radiol; 2016 Aug; 85(8):1400-6. PubMed ID: 27423679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma: detection of blood supply from the right inferior phrenic artery by the use of multi-detector row CT.
    Kim HC; Chung JW; An S; Son KR; Jae HJ; Park JH
    J Vasc Interv Radiol; 2008 Nov; 19(11):1551-7. PubMed ID: 18818094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma: the role of helical biphasic contrast-enhanced CT versus CT during arterial portography.
    Kanematsu M; Oliver JH; Carr B; Baron RL
    Radiology; 1997 Oct; 205(1):75-80. PubMed ID: 9314965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Time dependency of factors influencing survival of hepatocellular carcinoma patients with portal vein tumor thrombosis after surgery].
    Zhou J; Fan J; Tang ZY; Wu ZQ; Zhou XD; Ma ZC; Tan CJ; Shi YH; Yu Y; Qiu SJ
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):3005-8. PubMed ID: 17288818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.
    Liu H; Wang ZG; Fu SY; Li AJ; Pan ZY; Zhou WP; Lau WY; Wu MC
    Br J Surg; 2016 Mar; 103(4):348-56. PubMed ID: 26780107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcatheter arterial chemoembolization for advanced hepatocellular carcinoma with portal vein invasion: safety, efficacy, and prognostic factors.
    Chern MC; Chuang VP; Liang CT; Lin ZH; Kuo TM
    J Vasc Interv Radiol; 2014 Jan; 25(1):32-40. PubMed ID: 24290099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors.
    Choi D; Lim HK; Rhim H; Kim YS; Yoo BC; Paik SW; Joh JW; Park CK
    Ann Surg Oncol; 2007 Aug; 14(8):2319-29. PubMed ID: 17522947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.
    Yeh CN; Chen MF; Lee WC; Jeng LB
    J Surg Oncol; 2002 Dec; 81(4):195-202. PubMed ID: 12451624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular carcinoma: prediction of blood supply from an internal mammary artery with multi-detector row CT.
    Kim HC; Chung JW; Jae HJ; Jeon UB; Son KR; Park JH
    J Vasc Interv Radiol; 2008 Oct; 19(10):1419-25; quiz 1426. PubMed ID: 18693042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
    Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
    Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoembolotherapy for recurrent hepatocellular carcinoma in the residual liver after hepatectomy.
    Okazaki M; Yamasaki S; Ono H; Higashihara H; Koganemaru F; Kimura S; Kuroda Y; Sato S; Ryu K; Ohtsubo T
    Hepatogastroenterology; 1993 Aug; 40(4):320-3. PubMed ID: 8406299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiphase contrast-enhanced CT imaging in hepatocellular carcinoma correlation with immunohistochemical angiogenic activities.
    Kim YI; Chung JW; Park JH; Kang GH; Lee M; Suh KS; Kim KG
    Acad Radiol; 2007 Sep; 14(9):1084-91. PubMed ID: 17707316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.